Status:
COMPLETED
Effect of PRP Versus BMC in Anterior Cruciate Ligament Reconstruction
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Collaborating Sponsors:
Ministry of Health and Welfare, Taiwan
Conditions:
Anterior Cruciate Ligament Reconstruction
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Anterior cruciate ligament (ACL) is an important stabilizer of knee during daily activity and exercise. The ruptured ACL need to be reconstructed by a new tendon graft which passed the bone tunnel and...
Detailed Description
Anterior cruciate ligament (ACL) is an important stabilizer of knee during daily activity and exercise. According to literature, there are 100,000- 200,000 ACL tear case annually in US. The patients w...
Eligibility Criteria
Inclusion
- Age ≧ 20 year-old
- the patient has been confirmed ACL rupture and the reconstruction is indicated
- sign IRB and operation consent
Exclusion
- combined other ligament or extremities injury
- prior the same knee surgery
- open wound or operation history at knee joint
- Severe knee osteoarthritis
- history of multiple joint arthritis or rheumatoid arthritis
- Systemic diseases (infections, malignancies, immunodepression)
- patients with bleeding tendency, anticoagulant or antiaggregant therapies
- patients with Hb values \< 11 g/dl and/or platelet values \< 150,000/mm
- refuse to sign Informed Consent Form and operation consent
Key Trial Info
Start Date :
August 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 4 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05191732
Start Date
August 3 2018
End Date
July 4 2020
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 807